Health Products

Advia Centaur CP System- B-Type Natriuretic Peptide (BNP) Assay (2014-03-24)

· Published by Health Canada · Official notice

Details

Alert type: Medical Device Recall
Category: Medical Device
Issue: Medical Devices
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type III
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberCompaniesBrand nameModel or catalog number
038172
Manufacturer
Siemens Healthcare Diagnostics Inc.
511 Benedict Ave.
Tarrytown
10591
New York
UNITED STATES
Advia Centaur CP System- B-Type Natriuretic Peptide (BNP) Assay02816138

Introduction

Recalled Products

Advia Centaur CP System- B-Type Natriuretic Peptide (BNP) Assay

Reason

Siemens Healthcare Diagnostics has received complaints of failed calibrations on the Advia Centaur CP system when using BNP kit lots ending in 172. Siemens has confirmed that the failed calibration is due to an error on the Advia Centaur CP master curve card. The master curve card error results in a low calibration deviation outside the specified calibration evaluation range when using kit lots ending in 172 on the Advia Centaur CP only. An invalid calibration status will prevent BNP results from being generated. The master curve card contained in kit lots ending in 172 for the Advia Centaur and Advia Centaur XP platforms is not impacted and there is no calibration issue when using BNP kit lots ending in 172 on those systems.
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime